首页> 外文OA文献 >Using Pre-existing Microarray Datasets to Increase Experimental Power: Application to Insulin Resistance
【2h】

Using Pre-existing Microarray Datasets to Increase Experimental Power: Application to Insulin Resistance

机译:使用现有的微阵列数据集提高实验能力:在胰岛素抵抗中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although they have become a widely used experimental technique for identifying differentially expressed (DE) genes, DNA microarrays are notorious for generating noisy data. A common strategy for mitigating the effects of noise is to perform many experimental replicates. This approach is often costly and sometimes impossible given limited resources; thus, analytical methods are needed which increase accuracy at no additional cost. One inexpensive source of microarray replicates comes from prior work: to date, data from hundreds of thousands of microarray experiments are in the public domain. Although these data assay a wide range of conditions, they cannot be used directly to inform any particular experiment and are thus ignored by most DE gene methods. We present the SVD Augmented Gene expression Analysis Tool (SAGAT), a mathematically principled, data-driven approach for identifying DE genes. SAGAT increases the power of a microarray experiment by using observed coexpression relationships from publicly available microarray datasets to reduce uncertainty in individual genes' expression measurements. We tested the method on three well-replicated human microarray datasets and demonstrate that use of SAGAT increased effective sample sizes by as many as 2.72 arrays. We applied SAGAT to unpublished data from a microarray study investigating transcriptional responses to insulin resistance, resulting in a 50% increase in the number of significant genes detected. We evaluated 11 (58%) of these genes experimentally using qPCR, confirming the directions of expression change for all 11 and statistical significance for three. Use of SAGAT revealed coherent biological changes in three pathways: inflammation, differentiation, and fatty acid synthesis, furthering our molecular understanding of a type 2 diabetes risk factor. We envision SAGAT as a means to maximize the potential for biological discovery from subtle transcriptional responses, and we provide it as a freely available software package that is immediately applicable to any human microarray study.
机译:尽管它们已成为鉴定差异表达(DE)基因的一种广泛使用的实验技术,但DNA微阵列因产生嘈杂数据而臭名昭著。减轻噪声影响的常用策略是执行许多实验重复。如果资源有限,这种方法通常成本很高,有时甚至是不可能的。因此,需要无需额外成本即可提高准确性的分析方法。一种廉价的微阵列复制品来源来自先前的工作:迄今为止,成千上万的微阵列实验数据已在公共领域。尽管这些数据分析的条件范围很广,但它们不能直接用于任何特定的实验,因此大多数DE基因方法都忽略了它们。我们介绍了SVD增强基因表达分析工具(SAGAT),这是一种基于数学原理的数据驱动方法,用于鉴定DE基因。 SAGAT通过使用从公开可用的微阵列数据集中观察到的共表达关系来减少单个基因表达测量的不确定性,从而提高了微阵列实验的能力。我们在三个完全复制的人类微阵列数据集上测试了该方法,并证明了SAGAT的使用可将有效样本量增加多达2.72个阵列。我们将SAGAT应用于微阵列研究的未发表数据,该研究调查了对胰岛素抵抗的转录反应,导致检测到的重要基因数量增加了50%。我们使用qPCR通过实验评估了这些基因中的11个(58%),确认了所有11个基因的表达变化方向和三个基因的统计学意义。 SAGAT的使用揭示了三种途径的一致生物学变化:炎症,分化和脂肪酸合成,这进一步加深了我们对2型糖尿病危险因素的分子理解。我们设想将SAGAT作为一种手段,可以最大程度地利用微妙的转录反应进行生物学发现,并且将其作为免费提供的软件包提供,可立即应用于任何人类微阵列研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号